Wall Street Associates’s Imperva, Inc. IMPV Stock Holding History

Wall Street Associates’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-178,800	Closed	-$8.61M	–	352
2013 Q4	$8.61M	Buy	178,800 +33,300	+23%	+$1.4M	0.71%	41
2013 Q3	$6.11M	Sell	145,500 -1,600	-1%	-$76.2K	0.57%	54
2013 Q2	$6.63M	Buy	+147,100	New	+$5.77M	0.68%	46

Other funds holding IMPV

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wall Street Associates's IMPV Position: Q1 2014 in Review

Wall Street Associates sold out of Imperva, Inc. (IMPV) in Q1 2014, closing a stake of 178,800 shares — an estimated $8.61M sold.

Wall Street Associates first reported a position in IMPV in Q2 2013 and held it in 3 quarters. The position peaked at $8.61M in Q4 2013. 130 funds tracked by Wall St. Rank hold IMPV as of Q1 2014.

Wall Street Associates reported no remaining Imperva, Inc. position as of Q1 2014 after selling out during the quarter.
Wall Street Associates sold 178,800 Imperva, Inc. shares in Q1 2014, an estimated $8.61M.
Wall Street Associates first reported a position in Imperva, Inc. in Q2 2013 and held it in 3 quarters.
Wall Street Associates's Imperva, Inc. position peaked at $8.61M in Q4 2013.
130 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2014.

Based on Wall Street Associates's 13F filing for Q1 2014, filed 13 May 2014.